Glen Spraggon
10Patents
2h-index
25Co-inventors
50Inventor score
Filing activity: May 15, 2007 → Feb 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7951823B2 | Compounds and compositions as channel activating protease inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11634497B2 | Anti-CCR7 antibody drug conjugates | Chemistry; Metallurgy | 2 | Active |
| US7939547B2 | Compounds and compositions as channel activating protease inhibitors | Human Necessities | 2 | Active |
| US11930837B2 | Antibody-cytokine engrafted proteins and methods of use for immune related disorders | Chemistry; Metallurgy | 0 | Active |
| US11136366B2 | Methods of treating immune related disorders using antibody-cytokine engrafted compositions | Chemistry; Metallurgy | 0 | Active |
| US12006354B2 | Antibody-IL2 engrafted proteins and methods of use in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US12180291B2 | Anti-CCR7 antibody drug conjugates | Chemistry; Metallurgy | 0 | Active |
| US8338469B2 | Compounds and compositions as channel activating protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10144768B2 | Antibody cytokine engrafted compositions and methods of use for immunoregulation | Chemistry; Metallurgy | 0 | Active |
| US11122825B2 | Antibody-cytokine engrafted proteins and methods of use for immune related disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.